Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Anticancer Research

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 15330152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.

  2003cited by this paper
• Disparity between DNA base excision repair in yeast and mammals: translational implications.

  2003cited by this paper
• Temozolomide: realizing the promise and potential

  2003cited by this paper
• Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas.

  2002cited by this paper
• Structural analysis of an Escherichia coli endonuclease VIII covalent reaction intermediate

  2002cited by this paper
• Selenomethionine regulation of p53 by a ref1-dependent redox mechanism

  2002cited by this paper
• An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3′ mispaired DNA

  2002cited by this paper
• A novel fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase.

  2001cited by this paper
• GM-CSF increases AP-1 DNA binding and Ref-1 amounts in human alveolar macrophages.

  2001cited by this paper
• Histology-Specific Expression of a DNA Repair Protein in Pediatric Rhabdomyosarcomas

  2001cited by this paper
• Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.

  2001cited by this paper
• Base Excision Repair Intermediates as Topoisomerase II Poisons*

  2001cited by this paper
• Ref-1 and transcriptional control of endothelial apoptosis.

  2001cited by this paper
• DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.

  2001cited by this paper
• AP endonucleases and the many functions of Ref-1.

  2001cited by this paper
• Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas.

  2001cited by this paper
• Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas.

  2001cited by this paper
• Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.

  2001cited by this paper
• Future directions for temozolomide therapy.

  2001cited by this paper
• Redox Regulation of the DNA Repair Function of the Human AP Endonuclease Ape1/ref-1

  2001cited by this paper
• A Novel Action of Human Apurinic/Apyrimidinic Endonuclease

  2000cited by this paper
• Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions.

  2000cited by this paper
• Protection against Methylation-induced Cytotoxicity by DNA Polymerase β-Dependent Long Patch Base Excision Repair*

  2000cited by this paper
• Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.

  2000cited by this paper
• Going APE over ref-1.

  2000cited by this paper
• Accelerated regression of brain metastases in patients receiving whole brain radiation and the topoisomerase II inhibitor, lucanthone.

  1999cited by this paper
• Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis.

  1998cited by this paper
• Creation of a Fully Functional Human Chimeric DNA Repair Protein

  1998cited by this paper
• Complexities of DNA base excision repair in mammalian cells.

  1997cited by this paper
• Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells.

  1997cited by this paper
• 3'-phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends.

  1997cited by this paper
• Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy.

  1997cited by this paper
• Apurinic Sites Are Position-specific Topoisomerase II Poisons*

  1997cited by this paper
• The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer.

  1997cited by this paper
• Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease.

  1994cited by this paper
• Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme,APEX nuclease

  1994cited by this paper
• Repair of oxidative damage to DNA: enzymology and biology.

  1994cited by this paper
• A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress.

  1994cited by this paper
• Mutagenic processing of ethylation damage in mammalian cells: the use of methoxyamine to study apurinic/apyrimidinic site-induced mutagenesis.

  1993cited by this paper
• Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding

  1993cited by this paper
• Identification and characterization of Ref‐1, a nuclear protein that facilitates AP‐1 DNA‐binding activity.

  1992cited by this paper
• Two distinct human DNA diesterases that hydrolyze 3'-blocking deoxyribose fragments from oxidized DNA.

  1991cited by this paper
• The enzymology of apurinic/apyrimidinic endonucleases.

  1990cited by this paper
• A new approach to the study of the base-excision repair pathway using methoxyamine.

  1985cited by this paper

• Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives

  2025cites this paper
• APE1 condensation in nucleoli of non-cancer cells depends on rRNA transcription and forming G-quadruplex RNA structures

  2025cites this paper
• Contrasting roles of APE1 and APE2 in genome maintenance, cancer development, and therapeutic targeting

  2025cites this paper
• Exploring the Potential of Moringa Oleifera Phytochemicals as Inhibitors of Dipeptidyl Peptidase-4 (DPP-4) in Diabetes Mellitus: A Molecular Docking Approach

  2024cites this paper
• AP endonuclease 1: Biological updates and advances in activity analysis.

  2024cites this paper
• How to sensitize glioblastomas to temozolomide chemotherapy: a gap-centered view

  2024cites this paper
• Role of APE1 in hepatocellular carcinoma and its prospects as a target in clinical settings (Review)

  2024cites this paper
• Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo

  2024cites this paper
• Targeting APE1: Advancements in the Diagnosis and Treatment of Tumors.

  2024cites this paper
• Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma

  2024cites this paper
• Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons

  2023cites this paper
• Systematic approach to identify therapeutic targets and functional pathways for the cervical cancer

  2023cites this paper
• Bis-Cinnamamide Derivatives as APE/Ref-1 Inhibitors for the Treatment of Human Melanoma

  2022cites this paper
• Knockout and Inhibition of Ape1: Roles of Ape1 in Base Excision DNA Repair and Modulation of Gene Expression

  2022cites this paper
• Base excision repair accessory factors in senescence avoidance and resistance to treatments

  2022cites this paper
• A novel ligand swing-mediated active site coordination change of human apurinic/apyrimidinic endonuclease 1: A potential cytotoxic mechanism of nickel ion in the base excision repair

  2022cites this paper
• APE1/Ref-1 Role in Inflammation and Immune Response

  2022cites this paper
• Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo

  2022cites this paper
• Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation

  2021cites this paper
• Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells

  2021cites this paper
• Understanding APE1 cellular functions by the structural preference of exonuclease activities

  2021cites this paper
• Mechanisms of Resistance to Conventional Therapies for Osteosarcoma

  2021cites this paper
• DNA Repair Pathways in Cancer Therapy and Resistance

  2021cites this paper
• The Biological Role of Apurinic/Apyrimidinic Endonuclease1/Redox Factor-1 as a Therapeutic Target for Vascular Inflammation and as a Serologic Biomarker

  2020cites this paper
• Base excision repair pathways of bacteria: new promise for an old problem.

  2020cites this paper
• Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

  2020cites this paper
• Heavy Metal Phytotoxicity: DNA Damage

  2020cites this paper
• Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads

  2019cites this paper
• The Development of Novel Apurinic/Aprymidinic Endonuclease/Redox-factor 1 Inhibitors for the Treatment of Human Melanoma

  2019cites this paper
• Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma

  2019cites this paper
• A variant in a microRNA binding site in NEIL2 3′UTR confers susceptibility to age‐related cataracts

  2019cites this paper
• CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide

  2018cites this paper
• DNA Repair Enzymes as Promising Targets in Oncotherapy

  2018cites this paper
• APE1: A skilled nucleic acid surgeon

  2018cites this paper
• Nitric oxide induced S-nitrosation causes base excision repair imbalance.

  2018cites this paper
• Chapter 18 DNA Repair and Resistance to Cancer Therapy

  2017cites this paper
• A novel class of chemicals that react with abasic sites in DNA and specifically kill B cell cancers

  2017cites this paper
• Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking

  2017cites this paper
• DNA Base Excision Repair: The Achilles' Heel of Tumour Cells and their Microenvironment?

  2017cites this paper
• Targeting DNA repair pathways for cancer therapy

  2017cites this paper
• Lysosomal Biology in Cancer.

  2017cites this paper
• Base Excision Repair Manipulation in Breast Carcinoma: A Prospective Avenue to Potentiate Genome Insulting Approach

  2017cites this paper
• Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).

  2017cites this paper
• A novel acridine derivative, LS-1-10 inhibits autophagic degradation and triggers apoptosis in colon cancer cells

  2017cites this paper
• Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker

  2016cites this paper
• Repair Rate of Clustered Abasic DNA Lesions by Human Endonuclease: Molecular Bases of Sequence Specificity.

  2016cites this paper
• Carbon Nanotube- and Gold Nanoparticle-Based Materials For Electrochemical and Colorimetric Sensing Applications

  2016cites this paper
• Structure‐based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1

  2016cites this paper
• Novel pharmacological modulators of autophagy: an updated patent review (2012-2015)

  2016cites this paper
• Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme

  2016cites this paper
• Understanding the basics for translating the base excision repair pathway from benchtop to bedside in cancer treatment

  2016cites this paper
• Low APE 1 / Ref-1 expression significantly correlates with MGMT promoter methylation in patients with high-grade gliomas

  2016influential citation
• Graphene-based platforms for cancer therapeutics.

  2016cites this paper
• DNA Repair and Chemotherapy

  2015cites this paper
• Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways.

  2015cites this paper
• Design and activity of AP endonuclease-1 inhibitors

  2015cites this paper
• Computational prediction of Escherichia coli proteins host subcellular targeting and their implications in colorectal cancer etiology.

  2015cites this paper
• Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.

  2015cites this paper
• Resisting the Resistance in Cancer: Cheminformatics Studies on Short- Path Base Excision Repair Pathway Antagonists Using Supervised Learning Approaches.

  2015cites this paper
• Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics.

  2014cites this paper
• On-bead fluorescent DNA nanoprobes to analyze base excision repair activities.

  2014cites this paper
• APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions

  2014cites this paper
• Molecular mechanisms of chemoresistance in osteosarcoma (Review)

  2014cites this paper
• Standing the test of time: targeting thymidylate biosynthesis in cancer therapy

  2014cites this paper
• Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy

  2014cites this paper
• Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer

  2014cites this paper
• DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.

  2014cites this paper
• Physiological modulation approaches to improve cancer chemotherapy : a review.

  2014cites this paper
• Human Apurinic/Apyrimidinic Endonuclease 1

  2014cites this paper
• Dysregulation of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in advanced retinoblastoma

  2014cites this paper
• Inhibition of DNA Repair as a Therapeutic Target

  2014cites this paper
• Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited.

  2013cites this paper
• Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer

  2013cites this paper
• Nanostructures d'ADN supportées sur billes magnétiques de nouveaux outils senseurs des systèmes de réparation de l'ADN

  2013cites this paper
• Downregulation of Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Enhances the Sensitivity of Human Pancreatic Cancer Cells to Radiotherapy In Vitro

  2013cites this paper
• TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy

  2013cites this paper
• Genetic Instability of Cancer: Biological Predictions and Clinical Implications

  2013cites this paper
• Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue

  2013cites this paper
• The Role of Autophagy in Drug Resistance and Potential for Therapeutic Targeting

  2013cites this paper
• INFLUÊNCIA DO GENE APE1/REF-1 NAS RESPOSTAS CELULARES DAS LINHAGENS DE GLIOBLASTOMA AO QUIMIOTERÁPICO TEMOZOLOMIDA

  2013cites this paper
• Apurinic/apyrimidinic endonuclease(cid:2)1 (APE(cid:2)1) is overexpressed via the activation of NF(cid:2) κ B(cid:2)p65 in MCP(cid:2)1(cid:2)positive esophageal squamous cell carcinoma tissue

  2013cites this paper
• Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer

  2013cites this paper
• BRCAness: a deeper insight into basal-like breast tumors.

  2013cites this paper
• DNA Repair and Resistance to Cancer Therapy

  2013cites this paper
• MINISTÉRIO DA EDUCAÇÃO UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE

  2012cites this paper
• DNA repair dysregulation from cancer driver to therapeutic target

  2012cites this paper
• HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

  2012cites this paper
• Balancing repair and tolerance of DNA damage caused by alkylating agents

  2012cites this paper
• Two‐Photon Fluorescent Imaging of Myelination in the Spinal Cord

  2012cites this paper
• Receptor‐Based Virtual Screening and Biological Characterization of Human Apurinic/Apyrimidinic Endonuclease (Ape1) Inhibitors

  2012cites this paper
• DNA repair mechanisms protect our genome from carcinogenesis.

  2012cites this paper
• Base excision repair: contribution to tumorigenesis and target in anticancer treatment paradigms.

  2012influential citation
• Repair of 3-methyladenine and abasic sites by base excision repair mediates glioblastoma resistance to temozolomide

  2012cites this paper
• Exploring the Early Effects of AP Endonuclease 1 Knockdown in Zebrafish Embryogenesis

  2012cites this paper
• Autophagy as a target for cancer therapy: new developments

  2012cites this paper
• Avaliação dos mecanismos envolvidos na resposta aos danos no DNA induzidos pelo agente antitumoral 5-fluorouracil

  2012cites this paper
• Blockade of Base Excision Repair: Inhibition of Small Lesions Results in Big Consequences to Cancer Cells

  2012cites this paper
• The Identification and Characterization of Human AP Endonuclease-1 Inhibitors

  2012cites this paper
• Saccharomyces cerevisiae as a model system to study the response to anticancer agents

  2012cites this paper
• Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors.

  2012cites this paper